BetterNight is a virtual care platform including telehealth and remote patient monitoring for those with sleep apnea as well as a digital therapeutic solution based on cognitive behavioral therapy for those who suffer from insomnia.
ESPs containing BetterNight
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The companies in this market develop digital therapeutics to treat sleep disorders, such as chronic insomnia and sleep deprivation. Many provide digital apps that deliver cognitive behavioral therapy for insomnia (CBT-I).
Compete with BetterNight?
Ensure that your company and products are accurately represented on our platform.
BetterNight's Products & Differentiators
BetterNight is the nation’s only comprehensive virtual-care sleep solution combining a clinically validated sleep assessment with a CBTi solution and a telehealth-based sleep apnea platform. Results include lower unit costs, superior adherence, improved patient satisfaction, and higher health outcomes.
Research containing BetterNight
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BetterNight in 1 CB Insights research brief, most recently on Sep 20, 2022.
Expert Collections containing BetterNight
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BetterNight is included in 7 Expert Collections, including Digital Health.
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
Sleep Health & Wellness
These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Health Monitoring & Diagnostics
Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics
BetterNight has filed 2 patents.
Evidence law, Biometrics, Sleep disorders, Commercial aviators, Sleep
Evidence law, Biometrics, Sleep disorders, Commercial aviators, Sleep
Latest BetterNight News
May 10, 2022
By Chaunie Brusie, RN, BSN Everyone has experienced nights of poor sleep or external commitments that necessitate getting up early or going to bed late, but not all forms of sleep testing account for, or even measure, those variables or other causes of night-to-night variability, says Amy Bender, PhD, director of clinical sleep science at sleep diagnostics company Cerebra. Night-to-night variability—how much an individual’s sleep changes from night to night and encompassing aspects such as sleep quality, stage duration, length, and number of respiratory events—can make a difference in diagnosis and clinical care. Tracking night-to-night variability can also help identify triggers that could make both the symptoms of sleep disorders and any other medical conditions worse. For instance, drinking alcohol could disrupt someone’s sleep and change the symptoms of sleep apnea on the nights that alcohol is consumed. Bender and co-investigators recently studied the night-to-night variability data for 18 participants who recorded their sleep with in-home polysomnography over 14 to 31 nights. The study used an EEG metric named “Odds Ratio Product (ORP)” to analyze the data.1 ORP is available through the Cerebra Sleep System , a home sleep test that is available for clinical use in Canada and pending US Food and Drug Administration clearance. “Based on our recent study, it would take approximately 10 nights to really understand and get a good picture of someone’s sleep quality,” Bender says. “While there were large differences between subjects, the variability across nights within subjects was fairly small. But there were outliers indicating that future research could focus on what specific daily activities and lifestyle factors contribute significantly to individual variation in sleep quality across nights,” she says. Fortunately, there are more options than ever for measuring night-to-night variability and allowing patients the options to have sleep testing done at home in an environment most conducive for accurately capturing variability and disease severity. How Night-to-Night Variability May Impact Diagnosis Alan R. Schwartz, MD, adjunct professor at the University of Pennsylvania Perelman School of Medicine and part-time faculty at Vanderbilt University School of Medicine, explains that without sleep testing that looks at multiple nights, sleep practitioners may miss crucial information that can guide a diagnosis. “We may not capture the variability if we just record for one night,” says Schwartz, who is also professor (ret. ), Johns Hopkins University, a trainer with Zoll Itamar’s PAT Academy , and scientific advisor with several start-ups wrestling with such variability for diagnostic and therapeutic purposes. “Depending on which night we happen to have recorded you, we might come up with mild or no apnea on one night or on the other hand, more severe on another night.” Accurately diagnosing sleep disorders requires the subject to actually sleep—and to achieve sleep in multiple stages—explains sleep specialist Sahil Chopra, MD, CEO and co-founder of Empower Sleep. For instance, both non-REM sleep, more prominent during the first half of the night, and REM sleep, more prominent in the later half, are necessary for the severity of sleep apnea to be accurately detected. “Sometimes, sleep apnea is worse during REM sleep; sometimes it’s worse during non-REM sleep,” Chopra says. But he points out that if a patient has REM sleep-dominant sleep apnea and only slept a few hours during their sleep testing, the severity of the disease would not be detected because there was an insufficient duration of sleep to reach REM. “There’s always going to be a difference in the subjective and objective quality of sleep; how you sleep is different every night and that is the night-to-night variability in sleep,” Chopra says. “But if something is sleeping differently every night, their disease will behave differently as well.” Dominic A. Munafo, MD, FABSM, chief medical officer at BetterNight says, “The bottom line is that things that impact sleep quality will lead to night-to-night variability and impact the severity of sleep apnea diagnosed, or if there is clinically significant apnea at all.” Additionally, identifying more severe nights than mild could tip the patient into a different category of diagnosis and treatment. “The most important issue of variability is not whether a patient is having a few more events one night or another, but whether they are having a large enough difference that they’re in a different diagnostic category,” says Munafo, who is also a volunteer assistant clinical professor at the University of California, San Diego. Factors That Influence Night-to-Night Variability Night-to-night variability happens to everyone, but the severity of the variability is dependent on many factors. There isn’t a way to predict how specifically the variability will be affected, but Munafo explains that some of the factors that have the most significant impact include things like body position (supine versus side), alcohol, medications, other medical conditions, body weight, stress, environment (such as sleeping in a new place versus sleeping at home), and smoking history. According to Chopra, altitude also has a “massive influence” on how well someone sleeps. For instance, he cites a recent patient whose sleep apnea was twice as severe in higher altitudes as compared to sea level. After recently traveling to Galveston from Denver, Chopra notes that the patient’s sleep apnea improved significantly. Additionally, Schwartz points out that environmental considerations that are outside of the patient’s control can play a significant role in night-to-night variability. For instance, if someone lives in a noisy city with sirens going off or beneath a flight path, their sleep may be disrupted by factors they can’t change easily. Measuring Night-to-Night Variability Knowing that night-to-night variability can impact the presentation of sleep disorders, diagnostic tools that account for it help ensure accuracy in assessment. The 18-person study highlighted the utility of using ORP to capture differences between subjects in sleep quality across 20 nights,1 Bender says. “ORP is a continuous index of sleep depth derived from the relation of EEG powers in different frequency ranges to each other. It ranges from 0 (pattern only occurring during sleep) to 2.5 (pattern only occurring during wakefulness or in arousals). As a continuous measure, it avoids the pitfalls of standard sleep staging, and it considers patterns across several frequencies of EEG. “However, it still took approximately 10 nights to get a clear picture of someone’s sleep quality because of fluctuations in daily activities (exercise, caffeine, alcohol) that plays a role at changing overall sleep quality.” Though it is rare for a patient to undergo 10 nights of sleep testing, some patients do get sleep studies for two or three consecutive nights. Night-to-night variability then becomes not an obstacle to detection but a crucial component of it. For instance, online telehealth company Empower Sleep ships devices to patients to use in their own sleep environments over multiple nights that include the SleepImage Ring, a wearable device that uses cardiopulmonary coupling to determine sleep apnea severity, as well as other products such as Zoll Itamar’s WatchPAT, ectosense’s NightOwl ( now owned by ResMed ), and REMWare’s DreamClear. Schwartz notes that the availability of at-home sleep testing devices allows clinicians the ability to see past some of the inaccuracies that night-to-night variability can have on the presentation of sleep disorder symptoms. “Any device that gives you multiple nights is going to overcome some of the issues; it doesn’t matter what the device is,” he says. “It’s really more of a question of if a device that provides you with multiple nights of testing can help build confidence that the results that you see are accurate and consistent.” At BetterNight, “if we see someone who needs a multiple night study, then we can give them an in-home study that goes over multiple nights,” says Munafo, who describes BetterNight as “technology-agnostic.” “We can adjust to differing clinical scenarios so as to do a better job detecting night-to-night variability to be sure someone really has or doesn’t have significant obstructive apnea. In addition, we track patients on CPAP therapy on a nightly basis, for as long as they are on therapy, to be sure they are adequately treated.” Devices that allow for more accurate diagnosis of the severity and presence of sleep disorders can then help guide treatment options, Chopra says. “It helps us personalize what we do,” he says. For instance, if a patient has primarily mild obstructive sleep apnea and moderate only on isolated nights, the clinician may opt to recommend a mandibular device over CPAP. Or, if measuring night-to-night variability and tracking factors (many of the devices include corresponding apps to input those notes) helps uncover that the patient only has sleep apnea on their back, but not on their side, a positional intervention may be used. “We use this variation in sleep that happens on a night-to-night basis and we use those objective interventions—things that worsen sleep and things that better sleep,” he says. A one-night lab test may not reveal that someone’s sleep apnea is worsened by alcohol intake, for instance, but logging behaviors, along with multiple-night testing, could reveal individual triggers and guide positive habit changes. “The bottom line is that now that we know that there is so much variation in sleep on a night-to-night basis, the future of sleep health needs to be mindful of that,” Chopra says. “We should not be treating people with a single night of sleep testing. You would never go to a primary care provider who would check your blood pressure once, prescribe your meds, then never check your blood pressure again —the same is true for sleep.” Chaunie Brusie, RN, BSN, is a content creator specializing in health, medical, parenting, finance, and travel. Reference 1. Bender A, Lambing K, Ariyibi B, et al. Night-to-night variability of sleep quality using Odds Ratio Product: an assessment of 14-31 nights of in-home polysomnography. Presented at World Sleep 2022. Available at https://ws2022.abstractserver.com/program/#/details/presentations/2262.
BetterNight Frequently Asked Questions (FAQ)
When was BetterNight founded?
BetterNight was founded in 1995.
Where is BetterNight's headquarters?
BetterNight's headquarters is located at 5471 Kearny Villa Road, San Diego.
What is BetterNight's latest funding round?
BetterNight's latest funding round is Loan.
How much did BetterNight raise?
BetterNight raised a total of $7.5M.
Who are the investors of BetterNight?
Investors of BetterNight include Paycheck Protection Program and HCAP Partners.
Who are BetterNight's competitors?
Competitors of BetterNight include mementor and 7 more.
What products does BetterNight offer?
BetterNight's products include BetterNight.
Compare BetterNight to Competitors
Dozy uses proven therapeutic techniques (CBT-i) to fix insomnia. Cognitive Behavioral Therapy for Insomnia, or CBT-i, is the most effective known treatment for insomnia. It's based on the principles of Cognitive Behavioral Therapy and improves sleep by training your brain's thought patterns. Treatment usually takes 5-10 weeks and effects are permanent.
NightWare develops an application on an Apple Watch that aims to help people suffering from nightmares. The company offers wearable technology that learns sleep patterns and customizes a treatment for each individual. NightWare was founded in 2015 and is based in Hopkins, Minnesota.
Big Health offers digital therapeutics servies including fully automated behavioral programs. The company offers Sleepio for users in need of help with sleep issues.
Embr Labs provides a wearable that aids women in instantly alleviating hot flashes at the press of a button. It was founded in 2014 and is based in Boston, Massachusetts.
Zeen Health develops medical-grade and clinically evaluated digital therapeutics (DTx) products for mental disorders, helping patients to diagnose, treat and manage their mental disorders and enjoy the convenience brought bytechnology.
Woebot is an automated conversational agent (chatbot) who helps users monitor their mood and learn about themselves. Drawing from a therapeutic framework known as Cognitive Behavior Therapy, Woebot asks people how they're feeling and what is going on in their lives in the format of brief daily conversations. Woebot is powered by artificial intelligence.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.